1
–
15
von
24,519
Ergebnisse

Sonderaktionen verfügbar
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P01133 |
Biologische Aktivität | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human EGF, Animal-Free |
Inhalt und Lagerung | -20°C |
Gensymbol | EGF |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | EGF |
Molekulargewicht | 6.2 kDa |
Expressionssystem | E. coli |
Sequenz | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
Zur Verwendung mit (Anwendung) | Functional Assay |
Endotoxin-Konzentration | <0.1 EU/ μg |
Gen-Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
Quelle | E. coli |
Gen-ID (Entrez) | 1950 |
Sonderaktionen verfügbar
Gibco™ Human FGF-basic (FGF-2/bFGF) (154 aa) Recombinant Protein, PeproTech®
Gibco™ Human FGF-basic (FGF-2/bFGF) (154 aa) Recombinant Protein, PeproTech®
Recombinant Protein
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P09038 |
Biologische Aktivität | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
Inhalt und Lagerung | -20°C |
Gensymbol | FGF2 |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | FGF2 |
Molekulargewicht | 17.2 kDa |
Expressionssystem | E. coli |
Sequenz | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
Quelle | E. coli |
Gen-ID (Entrez) | 2247 |
Sonderaktionen verfügbar
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Recombinant Protein
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P21237, P23363, P23560 |
Biologische Aktivität | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human/Mouse/Rat BDNF |
Inhalt und Lagerung | -20°C |
Gensymbol | BDNF |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | BDNF |
Molekulargewicht | 27 kDa |
Expressionssystem | E. coli |
Sequenz | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
Quelle | E. coli |
Gen-ID (Entrez) | 12064, 24225, 627 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P01375 |
Biologische Aktivität | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human TNF-alpha |
Inhalt und Lagerung | -20°C |
Gensymbol | Tnf |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | TNF alpha |
Molekulargewicht | 17.4 kDa |
Expressionssystem | E. coli |
Sequenz | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF a; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFa; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1 F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
Quelle | E. coli |
Gen-ID (Entrez) | 7124 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P01579 |
Biologische Aktivität | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human IFN-gamma |
Inhalt und Lagerung | -20°C |
Gensymbol | IFNG |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | IFN gamma |
Molekulargewicht | 16.8 kDa |
Expressionssystem | E. coli |
Sequenz | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN ?; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFN?; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon ?; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferon?; M-IFN-g; R-IFN-g |
Quelle | E. coli |
Gen-ID (Entrez) | 3458 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P09603 |
Biologische Aktivität | The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human M-CSF |
Inhalt und Lagerung | -20°C |
Gensymbol | Csf1 |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | M-CSF |
Molekulargewicht | 36.8 kDa |
Expressionssystem | E. coli |
Sequenz | MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
Quelle | E. coli |
Gen-ID (Entrez) | 1435 |
Sonderaktionen verfügbar
Gibco™ Human TGF-beta 1 Recombinant Protein, PeproTech®
Gibco™ Human TGF-beta 1 Recombinant Protein, PeproTech®
Recombinant Protein
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P01137 |
Biologische Aktivität | The ED50 was determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human TGF-beta 1 |
Inhalt und Lagerung | -20°C |
Gensymbol | Tgfb1 |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | TGF beta-1 |
Molekulargewicht | 25 kDa |
Expressionssystem | HEK293 cells |
Sequenz | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
Zur Verwendung mit (Anwendung) | Functional Assay |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
Quelle | HEK293 cells |
Gen-ID (Entrez) | 7040 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P22301 |
Biologische Aktivität | Determined by the dose-dependent co-stimulation (with human IL-4) of MC/9 cells. The ED50 was found to be ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human IL-10 |
Inhalt und Lagerung | -20°C |
Gensymbol | IL10 |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | IL-10 |
Molekulargewicht | 18.6 kDa |
Expressionssystem | E. coli |
Sequenz | MSPGQGTQSE NSCTHFPGNL PNMLRDLRDA FSRVKTFFQM KDQLDNLLLK ESLLEDFKGY LGCQALSEMI QFYLEEVMPQ AENQDPDIKA HVNSLGENLK TLRLRLRRCH RFLPCENKSK AVEQVKNAFN KLQEKGIYKA MSEFDIFINY IEAYMTMKIR N |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | CSIF; cytokine; Cytokine synthesis inhibitory factor; GVHDS; H-IL-10; il 10; IL10; IL-10; IL-10 precursor; IL10A; IL10X; ILN; Interleukin; interleukin 10; Interleukin10; interleukin-10; MGC126450; MGC126451; RP11-262N9.1; T-cell growth inhibitory factor; TGIF |
Quelle | E. coli |
Gen-ID (Entrez) | 3586 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P60568 |
Biologische Aktivität | The ED50 as determined by the dose-dependent stimulation of murine CTLL-2 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human IL-2 |
Inhalt und Lagerung | -20°C |
Gensymbol | IL2 |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | IL-2 |
Molekulargewicht | 15.5 kDa |
Expressionssystem | E. coli |
Sequenz | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFAQSII STLT |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
Quelle | E. coli |
Gen-ID (Entrez) | 3558 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P15692 |
Biologische Aktivität | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human VEGF-165 |
Inhalt und Lagerung | -20°C |
Gensymbol | VEGFA |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | VEGF-165 |
Molekulargewicht | 38.2 kDa |
Expressionssystem | E. coli |
Sequenz | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
Quelle | E. coli |
Gen-ID (Entrez) | 7422 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P04141 |
Biologische Aktivität | The ED50 as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human GM-CSF |
Inhalt und Lagerung | -20°C |
Gensymbol | CSF2 |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | GM-CSF |
Molekulargewicht | 14.6 kDa |
Expressionssystem | E. coli |
Sequenz | MAPARSPSPS TQPWEHVNAI QEARRLLNLS RDTAAEMNET VEVISEMFDL QEPTCLQTRL ELYKQGLRGS LTKLKGPLTM MASHYKQHCP PTPETSCATQ IITFESFKEN LKDFLLVIPF DCWEPVQE |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; molgramostin; put. GM-CSF; sargramostim |
Quelle | E. coli |
Gen-ID (Entrez) | 1437 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P04085 |
Biologische Aktivität | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells. The expected ED50 for this effect is 1.0-3.0 ng/ml |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human PDGF-AA |
Inhalt und Lagerung | -20°C |
Gensymbol | Pdgfa |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | PDGF-AA |
Molekulargewicht | 28.5 kDa |
Expressionssystem | E. coli |
Sequenz | SIEEAVPAV CKTRTVIYEI PRSQVDPTSA NFLIWPPCVE VKRCTGCCNT SSVKCQPSRV HHRSVKVAKV EYVRKKPKLK EVQVRLEEHL ECACATTSLN PDYREEDTGR PRESGKKRKR KRLKPT |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | H-PDGF-AA; PDGF A-chain; PDGF subunit A; PDGF1; PDGF-1; Pdgfa; PDGF-A; PDGFACP; platelet derived growth factor subunit A; platelet derived growth factor, alpha; Platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor subunit A; Rpa1 |
Quelle | E. coli |
Gen-ID (Entrez) | 5154 |
Gensymbol | IL1B |
---|---|
Zusammensetzung | protein with no preservative |
Kennzeichnung | RUO |
Rekombinant | Recombinant |
Form | Lyophilized |
Sequenz | APVRSLNCTL RDSQQKSLVM SGPYELKALH LQGQDMEQQV VFSMSFVQGE ESNDKIPVAL GLKEKNLYLS CVLKDDKPTL QLESVDPKNY PKKKMEKRFV FNKIEINNKL EFESAQFPNW YISTSQAENM PVFLGGTKGG QDITDFTMQF VSS |
Konjugat | Unconjugated |
Zur Verwendung mit (Anwendung) | ELISA,Functional Assay,Western Blot |
Zugriffsnummer | P01584 |
Quelle | E. coli |
Reinheits- oder Qualitätsgrad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Name | Human IL-1 beta |
Gen-ID (Entrez) | 3553 |
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | P14210 |
Biologische Aktivität | Determined by the dose-dependent stimulation of the proliferation of monkey 4 MBr-5 cells. The expected ED50 for this effect is 1.0-20.0 ng/ml |
Reinheits- oder Qualitätsgrad | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Name | Human HGF |
Inhalt und Lagerung | -20°C |
Gensymbol | Hgf |
Zusammensetzung | protein with no preservative |
Gebräuchliche Bezeichnung | HGF |
Molekulargewicht | 79.4 kDa |
Expressionssystem | HEK293 cells |
Sequenz | Alpha chain: KRRNTIHEFK KSAKTTLIKI DPALKIKTKK VNTADQCANR CTRNKGLPFT CKAFVFDKAR KQCLWFPFNS MSSGVKKEFG HEFDLYENKD YIRNCIIGKG RSYKGTVSIT KSGIKCQPWS SMIPHEHSFL PSSYRGKDLQ ENYCRNPRGE EGGPWCFTSN PEVRYEVCDI PQCSEVECMT CNGESYRGLM DHTESGKICQ RWDHQTPHRH KFLPERYPDK GFDDNYCRNP DGQPRPWCYT LDPHTRWEYC AIKTCADNTM NDTDVPLETT ECIQGQGEGY RGTVNTIWNG IPCQRWDSQY PHEHDMTPEN FKCKDLRENY CRNPDGSESP WCFTTDPNIR VGYCSQIPNC DMSHGQDCYR GNGKNYMGNL SQTRSGLTCS MWDKNMEDLH RHIFWEPDAS KLNENYCRNP DDDAHGPWCY TGNPLIPWDY CPISRCEGDT TPTIVNLDHP VISCAKTKQL R Beta chain: VVNGIPTRTN IGWMVSLRYR NKHICGGSLI KESWVLTARQ CFPSRDLKDY EAWLGIHDVH GRGDEKCKQV LNVSQLVYGP EGSDLVLMKL ARPAVLDDFV STIDLPNYGC TIPEKTSCSV YGWGYTGLIN YDGLLRVAHL YIMGNEKCSQ HHRGKVTLNE SEICAGAEKI GSGPCEGDYG GPLVCEQHKM RMVLGVIVPG RGCAIPNRPG IFVRVAYYAK WIHKIILTYK VPQS |
Zur Verwendung mit (Anwendung) | Functional Assay |
Endotoxin-Konzentration | <1 EU/ μg |
Gen-Alias | C230052L06Rik; DFNB39; Fibroblast derived tumor cytotoxic factor; fibroblast-derived tumor cytotoxic factor; F-TCF; hepatocyte growth factor; Hepatocyte growth factor (hepapoietin A; hepatocyte growth factor (hepapoietin A; scatter factor); Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain; Hepatopoeitin A; hepatopoeitin-A; HepatopoietinA; hepatopoietin-A; Hgf; HGF/SF; HGFB; HPTA; Lung fibroblast derived mitogen; lung fibroblast-derived mitogen; NK1; NK2; Scatter factor; scatter factor); SF; SF/HGF |
Quelle | HEK293 cells |
Gen-ID (Entrez) | 3082 |
Sonderaktionen verfügbar
Gibco™ Human R-Spondin 1 Recombinant Protein, PeproTech®
Gibco™ Human R-Spondin 1 Recombinant Protein, PeproTech®
Recombinant Protein
Kennzeichnung | RUO |
---|---|
Rekombinant | Recombinant |
Form | Lyophilized |
Konjugat | Unconjugated |
Zugriffsnummer | Q2MKA7 |
Reinheits- oder Qualitätsgrad | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Name | Human R-Spondin 1 |
Gensymbol | RSPO1 |
Zusammensetzung | protein with no preservative |
Sequenz | SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKQQLCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKGQQQQQQ QGTVGPLTSA GPA |
Zur Verwendung mit (Anwendung) | Functional Assay |
Gen-Alias | CRISTIN3; cristin-3; cysteine-rich and single thrombospondin domain-containing protein 3; FLJ40906; hRspo1; mCristin-3; RGD1565558; Roof plate-specific spondin-1; RP11-566C13.1; RSPO; RSPO1; Rspondin; R-spondin; R-spondin 1; R-spondin homolog; R-spondin homolog (Xenopus laevis); R-spondin-1; thrombospondin type 1 domain containing gene Rspondin |
Quelle | CHO cells |
Gen-ID (Entrez) | 284654 |